Atara Biotherapeutics Inc...

NASDAQ: ATRA · Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 3:59 PM
12.74
4.08%
After-hours: Aug 15, 2025, 07:47 PM EDT

Atara Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-85.4M -276.13M -228.3M -340.14M
Depreciation & Amortization
4.81M 4.83M 5.65M 9.35M
Stock-Based Compensation
27M 45.39M 53.84M 53.87M
Other Working Capital
-59.84M 20.48M -11.44M 39.91M
Other Non-Cash Items
15.83M 17.59M -40.15M 2.04M
Deferred Income Tax
n/a n/a n/a 1.79M
Change in Working Capital
-30.96M 15.34M -61.47M 52.58M
Operating Cash Flow
-68.72M -192.98M -270.43M -220.52M
Capital Expenditures
-246K -1.22M -4.19M -10.58M
Cash Acquisitions
n/a n/a 94.77M -32.84M
Purchase of Investments
-19.66M -83.65M -180.59M -301.13M
Sales Maturities Of Investments
28.54M 208.71M 292.97M 333.97M
Other Investing Acitivies
n/a 25K 207.15M 32.84M
Investing Cash Flow
8.62M 123.87M 202.96M 22.26M
Debt Repayment
-892K -947K -518K -254K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
223K 821K 54.23M 5.5M
Financial Cash Flow
59.28M 2.01M 53.08M 103.94M
Net Cash Flow
-811K -67.1M -14.39M -94.32M
Free Cash Flow
-68.96M -194.2M -274.62M -231.1M